About: A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 26 July 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в липні 2018 (uk) article scientifique publié en 2018 (fr) im Juli 2018 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xunetu de 2018 (ast) scientific article published on 26 July 2018 (en)
publication date	wds:Q58541787-BC857E30-5685-425A-A496-4AC173DFF911
publication date	2018-07-26 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58541787-C7A2AFF6-728D-4FC0-9D9C-A3FD5FAE1F44
language of work or name	English
cites work	wds:Q58541787-04B6CBB7-E3C2-4575-9157-C5D0670CC283 wds:Q58541787-05F0B06E-6CCC-4796-B0F3-07AE2F3AC086 wds:Q58541787-0BD8FD9C-4628-4E09-A4E5-79E6BC5FB85C wds:Q58541787-14BB1CBA-7539-4FB2-A7DA-9A2756382A05 wds:Q58541787-228F0C83-140E-4279-B36B-28DAEEA88DBA wds:Q58541787-3BE83386-1E03-4135-8E45-38FCEDC5B4A6 wds:Q58541787-3D07CC54-92F6-4A09-8198-4142396973B4 wds:Q58541787-4093AC67-F1AF-4399-A19B-57B68F9ADF5C wds:Q58541787-488399EE-0882-46A6-A1C7-596A3E0BBAD2 wds:Q58541787-4AE37CDD-33CC-4779-8A45-76ABBEF8B295 wds:Q58541787-52811141-B9FC-428B-91F6-28595FEBDFE7 wds:Q58541787-592BEFBE-00BC-4480-998C-57DDFB7E272F wds:Q58541787-685CD25D-5EBA-4179-8911-E9369117B19A wds:Q58541787-75BB5988-002F-43AB-9585-20A78DB46C49 wds:Q58541787-7632C871-79DC-473B-B2E5-D054EC3858B8 wds:Q58541787-7B8F614D-BFC9-40D9-A7EE-C3F6625167A5 wds:Q58541787-8621C425-9BCA-442A-937C-3FA1C165E476 wds:Q58541787-A4393498-6672-4BB0-9571-5D37F4E61CDD wds:Q58541787-A847D5D3-1689-4838-87A1-BBEB22D12360 wds:Q58541787-AAC0E939-F33E-4CE4-978B-1BD8FE891936 wds:Q58541787-CECBE192-DDBA-4E55-A3DF-0532C64204A8 wds:Q58541787-D4C19EFB-682D-429D-998E-206BBFF17C18 wds:Q58541787-E468DA22-CD97-4961-8312-D404921FAF4A wds:Q58541787-E6FEB4AE-7193-4CD0-A081-5DCE02FDDF47 wds:Q58541787-EB96AC4A-2D68-42EE-96EF-E6251150B0C4
cites work	Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. World-wide epidemiology of HBeAg-negative chronic hepatitis B and associated precore and core promoter variants Hepatitis B e antigen-negative chronic hepatitis B. Sustained response of hepatitis B e antigen-negative patients 3 years after treatment with peginterferon alpha-2a Randomised study comparing 48 and 96 weeks peginterferon α-2a therapy in genotype D HBeAg-negative chronic hepatitis B Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Predicting response to peginterferon alpha-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients Early on-treatment prediction of response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B using HBsAg and HBV DNA levels Validation of a stopping rule at week 12 using HBsAg and HBV DNA for HBeAg-negative patients treated with peginterferon alfa-2a Kinetics of hepatitis B surface antigen differ between treatment with peginterferon and entecavir A new role for an old marker, HBsAg Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B. Presentation of multivariate data for clinical use: The Framingham Study risk score functions Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. HBsAg quantification to optimize treatment monitoring in chronic hepatitis B patients Outcome of anti-HBe positive chronic hepatitis B in alpha-interferon treated and untreated patients: a long term cohort study Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B. Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study. Long-term hepatitis B surface antigen (HBsAg) kinetics during nucleoside/nucleotide analogue therapy: finite treatment duration unlikely On-treatment prediction of sustained response to peginterferon alfa-2a for HBeAg-negative chronic hepatitis B patients Quantification of serum hepatitis B surface antigen: is it useful for the management of chronic hepatitis B?
author name string	wds:Q58541787-25A0EFE5-A908-426F-A8A4-A4C51FC75AF2 wds:Q58541787-58C9A0DC-1A9E-4FF3-ADC7-BF02BE3351A5 wds:Q58541787-65E11A99-87FC-46A0-92AB-290FE0301538 wds:Q58541787-B47268B2-4121-4B02-956B-B782E2047B06 wds:Q58541787-B5F25208-0CD9-4002-9C5E-5F33C057206B wds:Q58541787-CEC933C4-860F-4805-8D4C-9228DE27D37E wds:Q58541787-D6B10560-672C-4063-9A9C-E8562DD9D939 wds:Q58541787-E72F52A0-7866-4A80-AD59-637F66CB06B6 wds:Q58541787-E933A359-22AF-43E3-B586-4A11C580BD3E
author name string	Patrick Kennedy George V Papatheodoridis Pietro Lampertico Diethelm Messinger Jörg Petersen Tarik Asselah Maurizia Brunetto Antonietta Caputo Vivien Rothe
rdfs:label	A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B (en) A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B (nl)
skos:prefLabel	A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B (en) A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B (nl)
name	A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B (en) A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B (nl)
author	wds:Q58541787-AC220176-698A-4769-A1A6-F1FF1C3FB386 wds:Q58541787-DB7D39B5-2AF3-4265-9857-5359B753A5F3 wds:Q58541787-FA46CE92-A7D1-4535-82FA-18A248EAF40F
author	Georgios Bakalos Markus Cornberg Vedran Pavlovic
title	wds:Q58541787-51696E76-E33D-4DD7-B74E-0BBE67C59E32
title	A genotype-specific baseline score predicts post-treatment response to peginterferon alfa-2a in hepatitis B e antigen-negative chronic hepatitis B (en)
page(s)	wds:Q58541787-62BE7A9F-26A8-4D88-B1AB-0F91915B01C3
page(s)	712-721
instance of	wds:Q58541787-3CC8D48D-613B-4DFD-A1FB-84A199D9EA4F
instance of	scholarly article
main subject	wds:Q58541787-0B67D878-AE00-4536-B30F-5594225A8495 wds:Q58541787-38B15DF0-851E-493C-B7FC-DA69BA02B726 wds:Q58541787-443F0082-13FB-47C2-9C4F-D167F370AF06

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software